AbbVie
ABBV
#29
Rank
HK$2.692 T
Marketcap
HK$1,525
Share price
1.75%
Change (1 day)
10.98%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): HK$28.81

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$28.61. In 2022 the company made an earnings per share (EPS) of HK$51.75 an increase over its 2021 EPS that were of HK$50.42.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$28.81-44.33%
2022HK$51.752.63%
2021HK$50.42125.21%
2020HK$22.39-45.69%
2019HK$41.2348.35%
2018HK$27.797.6%
2017HK$25.83-9.3%
2016HK$28.4715.48%
2015HK$24.66185.53%
2014HK$8.64-57.11%
2013HK$20.14-21.69%
2012HK$25.7155.73%
2011HK$16.51

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.46-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.86 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.20 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$109.98 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$34.12 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.48 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.21-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.43-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.23-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA